In conclusion, our study indicated that MLH1 plays an important role in improving the cisplatin sensitization of endometrial carcinoma cells through activation of the MLH1/c-Abl signaling pathway in vitro. This evidence concerns the gene ABL1 and endometrial carcinoma.